Drawing for ALZA

USPTO serial 75378154

ALZA

Reviewed by CopyMark Law Group

Reg. 2815218Status 710
Filing date
Status date
Registration date
Feb 17, 2004
Examiner
GAST, PAUL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LAURENCE S RICKLES

LAURENCE S RICKLES JOHNSON & JOHNSON1 JOHNSON & JOHNSON PLZNEW BRUNSWICK, NJ 08933-7001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical products, namely, those in specialized dosage forms, namely, transdermal plasters and transdermal patches used in pain relief, treatment of hypogonadism, and smoking cessation; iontophoretic patches for use in pain relief; controlled drug-releasing polymer matrices, for use in treatment of conditions of the oral cavity; and pharmaceutical products in conventional dosage forms, namely, fungicides, for treating oral fungal infections, alkalinizing agents for maintaining alkaline urine, alkalinizing agents for treating acidosis, alkalinizing agents for neutralizing gastric acid, bladder control drugs, anti-cancer drugs, drugs for relieving bladder pain, drugs for treating interstitial cystitis, drugs for reducing toxicity associated with chemotherapy, drugs for treating oral candidiasis, dietary and nutritional supplements, and drugs for use in the field of urology and oncology; and osmotic pumps for use in delivering cough/cold medications and for use in the field of urology and oncologySECTION 8 - CANCELLED—
010implantable drug delivery devices for use in experimental animals and for administering leuprolide in the treatment of prostate cancerSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2010C8..CANCELLED SEC. 8 (6-YR)—
Feb 17, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 28, 2003CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 29, 2003DOCKASSIGNED TO EXAMINER—
Sep 27, 2003CFITCASE FILE IN TICRS—
Sep 3, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 10, 2002MAILPAPER RECEIVED—
Jul 9, 2002IUAFUSE AMENDMENT FILED—
Jan 31, 2002EX2GSOU EXTENSION 2 GRANTED—
Jan 9, 2002EXT2SOU EXTENSION 2 FILED—
Jul 27, 2001EX1GSOU EXTENSION 1 GRANTED—
Jul 9, 2001EXT1SOU EXTENSION 1 FILED—
Jan 9, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2000NPUBNOTICE OF PUBLICATION—
Aug 17, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 8, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 6, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 1999DOCKASSIGNED TO EXAMINER—
Feb 26, 1999DOCKASSIGNED TO EXAMINER—
Dec 4, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance